The latest news from Arcinova
May 22, 2019
Mayor Jamie Driscoll Visits Our Alnwick Site
Our CEO and Chairman, Ian Shott a
May 9, 2019
Contract Pharma: ‘A Modern CDMO’ article
Our Head of Drug Substance, Paul Quigley, recently shared his thoughts on the
May 6, 2019
Dr Stephen Byard receives Award for Service
Morpeth’s Dr Stephen Byard has received The Royal Society of Chemistry Aw
April 26, 2019
Accelerating the path to first-in-human clinical trials
Our Head of Drug Substance, Paul Quigley, was recently interviewed by Outsourcing Pharma to coincide with his presentation at CPhI North America 2019. He explained the importance of ensuring rapid
April 17, 2019
Article: Chemistry 4.0 in pharmaceutical development
"The pharmaceutical industry is being revolutionised by the utilisation of digital technologies. Chemistry 4.0 describes this digital transformation and how its delivery is paving the way for the
April 16, 2019
Crédit d'impôt recherche Grants Arcinova with R&D Status
Arcinova has been recognised and approved by the Crédit d'impôt recherche (CIR) as an organisation undertaking R&D activities. This will bestow significant benefits upon any French cusDiscover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.
